![靶向Jagged1-依賴性腫瘤-基質(zhì)相互作用在乳腺癌癥骨轉(zhuǎn)移中的作用_第1頁](http://file4.renrendoc.com/view2/M03/28/0B/wKhkFmYrjluAMKQrAAL2z7PQ2_M416.jpg)
![靶向Jagged1-依賴性腫瘤-基質(zhì)相互作用在乳腺癌癥骨轉(zhuǎn)移中的作用_第2頁](http://file4.renrendoc.com/view2/M03/28/0B/wKhkFmYrjluAMKQrAAL2z7PQ2_M4162.jpg)
![靶向Jagged1-依賴性腫瘤-基質(zhì)相互作用在乳腺癌癥骨轉(zhuǎn)移中的作用_第3頁](http://file4.renrendoc.com/view2/M03/28/0B/wKhkFmYrjluAMKQrAAL2z7PQ2_M4163.jpg)
![靶向Jagged1-依賴性腫瘤-基質(zhì)相互作用在乳腺癌癥骨轉(zhuǎn)移中的作用_第4頁](http://file4.renrendoc.com/view2/M03/28/0B/wKhkFmYrjluAMKQrAAL2z7PQ2_M4164.jpg)
![靶向Jagged1-依賴性腫瘤-基質(zhì)相互作用在乳腺癌癥骨轉(zhuǎn)移中的作用_第5頁](http://file4.renrendoc.com/view2/M03/28/0B/wKhkFmYrjluAMKQrAAL2z7PQ2_M4165.jpg)
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
TargetingJagged1-DependentTumor-StromalInteractionsinBreastCancerBoneMetastasisDepartmentofMolecularBiology,PrincetonUniversityYibinKangBonemetastasisOsteolyticBoneMetastasisofBreastCancerNormalhttp://surgical-.uk
OsteoclastsBreastCancerCellsBoneOsteoblast/OsteocytesTheViciousCycleinBoneMetastasisEll&Kang,Cell,2012OsteoclastResorptionFormationBoneRANKLOPGOsteoblastTumorderivedfactorsTGF
IGFCa2+Korpaletal,NatureMedicine,2009Bone-deriveTGFFeedsBacktoTumorCellsP-Smad2stainingKorpaletal,NatureMedicine,2009SCP3SCP4SCP6SCP2SCP25SCP46IL11CTGFSKILSGKJUNBANGPTL4SPHK1JAG1CDKN1APLAURankinordereddatasetofbonemetastasisEnrichmentscore(ES)Coregeneset0.100.20.30.4Jagged1isOneoftheTGF-ResponsiveGenesintheBoneMetastasisGeneSetTGFβ(h)Jagged1β-actin061224Jagged1Delta-like1Delta-like4Delta-like1Jagged1Jagged267NR4T0766c144T1MetastasisabilityJagged1isAssociatedwithIncreasedRiskofBoneMetastasisJagged1ProbesSCP4SCP6SCP39ATCCSCP25SCP46SCP20SCP2WeakStrongBoneMetastaticActivity%BoneMet-freesurvivalYears05100255075100Logrankp=0.0327Jagged1Low(n=41)Jagged1High(n=41)Minnetal.dataset,82patientsinMSKCCBA-+-+ControlJagged1-KDTGFbJagged1
-actinADaysafterTumorInjectionBoneMetastasisBLI11010210310471421283542SCP2-ControlSCP2-Jagged1KD****Jagged1KnockdownInhibitsOsteolyticBoneMetastasisBControlJagged1KD05101520P=0.022ControlKDOsteolyticarea(mm2)C#TRAP+osteoclasts/mmboneinterfaceBBTTVectorJagged1KDTRAP01020304050P=0.007ControlKDSethi,etal,CancerCell,2011Jagged1-OverexpressionStimulatesTumorGrowthinCo-CulturewithOsteoblastsN1ICDHes1,Hey1….CSLNucleusSignal-sendingCellNotch1Jagged1
-Secretase
Complex
GSISignal-receivingCellN1ICD050100150200250300350Colonydiameter(μM)
DMSOGSIControlJagged1******ControlJagged1ControlJagged1DMSOGSI20x5xGFP/Luc+TumorCell+/-Jagged1MC3T3OsteoblastNotch1+Jagged1-OverexpressingTumorCellsStimulatesOsteoclastogenesisGFP/Luc+TumorCell+/-Jagged1RAW264.7Pre-osteoclastNotch1+TRAP+Osteoclasts05101520****DMSOGSIControlJagged1ControlJagged1DMSOGSIControlJagged1ControlJagged1TRAPStainingOsteoclastprogenitorBoneTGF
RI/IIOsteoblastTumorCellTumor-StromalCrosstalkinBoneMetastasisbyMediatedbyTGF
andNotchPathwaysOsteoclastJagged1/Notch1T
RinhibitorsGSI,Jagged1AbTGF
IL-6,CTGFNFATc171421283542BoneMetastasisBurden1101021030.1104Control+VehicleJagged1+Vehicle*DaysafterTumorInjectionNotchSignalingInhibitorGSIInhibitsJagged1-MediatedBoneMetastasisVector+GSI**Jagged1+GSISCP28ControlJagged1ControlJagged1VehicleGSIBBBBH&ETRAPBLIX-rayTTTTH&EAlcianblueControlJag1Ab(15D11)GSI(MRK-003)NoSignificantGITrackToxicityofJag1AbgobletcellmetaplasiaDay1:TumorXenograftDay0:15D1110mg/kg15D11or3mg/kgOPG,twiceweeklyfor5weeksCTIgGJag1AbOPG-FcSCP28-Jagged1OsteoclastsX-rayHealthyBoneSCP28-Jag1+OPG*SCP28-Jag1+Jag1Ab**SCP28-Jag1+IgGBoneMetastasisBurdenWeeksafterTumorInjection110102103104234561Jagged1AntibodyInhibitsJagged1-MediatedBoneMetastasisinPreventiveTreatmentProtocol10mg/kgJag1Ab,twiceweeklyfor4weeksDay1:TumorxenograftNotreatmentfor2weeksNoSignificantBenefitinLateTreatmentProtocol0501001502002345NormalizedBLISignalIgGJag1AbOPGN.S.SCP28-Jag1Weeks10mg/kgJag1Ab,twiceweeklyfor3weeksDay1:TumorxenograftNotreatmentfor1weeksCombinedJag1Ab/OPGTreatmentInhibitstheGrowthofEstablishedBoneMetastasis01002003004005006001234IgGJag1AbOPGJag1Ab+OPGP=0.02NormalizedBLIsignalIgGJag1AbOPGJag1Ab+OPGWeeksDay7Day280123451234567WeeksNormalizedBLI(log)IgGPaclitaxolJag1AbPaclitaxol+Jag1Ab6JaggedAbSensitizesBoneMetastasistoChemotherapyDay1:ICinjectionOneweeklater:AborchemotreatmentTwiceaweekWeek7:TerminalanalysisIgGPaclitaxolJag1AbPaclitaxol
+Jag1AbSCP28-Jag1TheStromalRoleofJagged1?Jagged1expressionissignificantlyelevatedinbonestromalcellsduringfactureandrepair,particularlyinMSCsandosteoblasts.Jagged1ishighlyexpressedinbonestromalcellsinmetastaticbonelesions,andisfurtherinducedinresponsetosystemictherapy.Notchsignalingisimportantforbonedevelopment.SkeletalDevelopmentDefectsofCola1-Jagged1TransgenicMiceCol1a1-Jag1WTCol1a1-Jag1WT***WTCol1a-Jag102004006008008008509009501000BD(mgHA/ccm)***50100150WTCol1a-Jag10TRAP+cells200WTCol1a-Jag1012345#Ob/BSWTCol1a-Jag101234#Oc/BS**IncreasedOsteoclastActivityinCola1-Jagged1TransgenicMiceWT
Col1a1-Jag1CtskInvivoInvitroIgGIgGJag1AbJag1AbWTCol1a1-Jag1Col1a1-Jag1Jag1AbCol11-Jag1
IgG
AbJag1AbTreatmentReversesBoneDefectsofCola1-Jagged1TransgenicMiceTRAPIntratibialinjection:Salineorbreastcancercells(1x104cells)3weeksWTTgBLIimagingmicroCTBonehistologyNormalizedBLI(Log)123WTCol1a-Jag104567***SalineCancerCellsWTSalineCancercellsCol1a-Jag1IncreasedFormationofExperimentalBoneMetastasisinCola1-Jagged1TransgenicMiceJagged1promotesosteolyticbonemetastasisbyengagingNotchsignalinginbonestromalcells.Jag1Ab(15D11)iseffectiveinblockingJagged1-dependentosteolyticbonemetastasis.Jagged1mayalsohaveothertumorpromotingfunction(e.g.chemoresistanceetc),whichcanalsobetargetedby15D11toachievesynergisticeffectwithchemotherapy.Overexpres
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025-2030全球手工巧克力行業(yè)調(diào)研及趨勢分析報告
- 2025年全球及中國天麻素制劑行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025年全球及中國三氟化銪行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025年全球及中國臺式化學(xué)發(fā)光免疫分析儀行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025-2030全球棱鏡膠帶片行業(yè)調(diào)研及趨勢分析報告
- 2025年全球及中國十六硫醇行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025-2030全球波紋型空氣彈簧行業(yè)調(diào)研及趨勢分析報告
- 2025年全球及中國高分辨率掃描電子顯微鏡(SEM)行業(yè)頭部企業(yè)市場占有率及排名調(diào)研報告
- 2025-2030全球紫外熔融石英平凸(PCX)透鏡行業(yè)調(diào)研及趨勢分析報告
- 2025-2030全球建筑垃圾分類設(shè)備行業(yè)調(diào)研及趨勢分析報告
- 課題申報參考:流視角下社區(qū)生活圈的適老化評價與空間優(yōu)化研究-以沈陽市為例
- 《openEuler操作系統(tǒng)》考試復(fù)習題庫(含答案)
- 項目重點難點分析及解決措施
- 挑戰(zhàn)杯-申報書范本
- 北師大版五年級上冊數(shù)學(xué)期末測試卷及答案共5套
- 2024-2025學(xué)年人教版生物八年級上冊期末綜合測試卷
- 2025年九省聯(lián)考新高考 語文試卷(含答案解析)
- 第1課《春》公開課一等獎創(chuàng)新教案設(shè)計 統(tǒng)編版語文七年級上冊
- 全過程工程咨詢投標方案(技術(shù)方案)
- 心理健康教育學(xué)情分析報告
- 安宮牛黃丸的培訓(xùn)
評論
0/150
提交評論